Guided Therapeutics (GTHP) Cash from Investing Activities (2011 - 2022)
Guided Therapeutics' (GTHP) quarterly Cash from Investing Activities came in at -$3000.0 in Q4 2022, up 25.0% year-on-year from -$2400.0 in Q4 2021, and up 78.57% quarter-over-quarter from -$14000.0 in Q1 2022.
Guided Therapeutics (GTHP) Cash from Investing Activities (2011 - 2022) Analysis & Trends
Guided Therapeutics has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$3000.0 for Q4 2022.
- Cash from Investing Activities for Q4 2022 came in at -$3000.0, up 25.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3000.0 (up 82.35% YoY), and the FY2025 annual result was -$2000.0, changed N/A from the prior year.
- Cash from Investing Activities came in at -$3000.0 for Q4 2022 at Guided Therapeutics, up from -$14000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1000.0 in Q3 2020 to a low of -$14000.0 in Q1 2022.
- The 3-year median for Cash from Investing Activities is -$4000.0 (2021), against an average of -$4571.4.
- Peak annual rise in Cash from Investing Activities reached 25.0% in 2022, while the deepest fall reached 1300.0% in 2022.
- Guided Therapeutics' Cash from Investing Activities stood at -$1000.0 in 2020, then slumped by 300.0% to -$4000.0 in 2021, then gained by 25.0% to -$3000.0 in 2022.
- The last three Cash from Investing Activities figures came in at -$3000.0 (Q4 2022), -$14000.0 (Q1 2022), and -$4000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Mar 31, 2022 | -14,000.00 |
| Mar 31, 2022 | -14,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Dec 31, 2014 | -6,000.00 |
| Dec 31, 2014 | -6,000.00 |